Mixed options sentiment in Bristol Myers Squibb (BMY), with shares up 36c, or 0.72%, near $49.41. Options volume roughly in line with average with 37k contracts traded and calls leading puts for a put/call ratio of 0.63, compared to a typical level near 0.84. Implied volatility (IV30) dropped 1.56 near 34.71,and above the 52wk median, suggesting an expected daily move of $1.08. Put-call skew steepened, indicating increased demand for downside protection.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Novo Nordisk Stock (NVO) Jumps after Ozempic and Wegovy Prices Cut 71% under Medicare Plan
- Bristol Myers says EC grants approval to Breyanzi for treatment of MCL
- Bayer data could ‘somewhat renew’ optimism for Bristol drug, says Morgan Stanley
- Video: Biogen up after Novo weight-loss drug fails to slow Alzheimer’s progress
- Texas AG sues Sanofi, Bristol Myers over alleged Plavix inefficacy